ANVISA registration
LISA-TRACKER ANTI-INFLIXIMAB
Registration 10338930315. ANTICORPOS ANTI-INFLIXIMAB (IFX)
Registration details
| Registration number | 10338930315 |
|---|---|
| Application number | 25351369547202453 |
| Technical name | ANTICORPOS ANTI-INFLIXIMAB (IFX) |
| Risk class | II |
| Published on | 22/07/2024 |
| Validity | Indefinite validity |
Registration holder
| Legal name | EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA |
|---|---|
| CNPJ | 93.741.726/0001-66 |
Manufacturer
- BIOSYNEX SA FRANÇA
Other registrations held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAview all
Anti-cardiolipina IgM
10338930040ANTI-TRANSGLUTAMINASE TECIDUAL ELISA IgA EA 1910-9601 A
10338930041ANTI-GLIADINA GAF-3X ELISA IGG EV3011-9601 G
10338930042ANTI-SSB ELISA IgG EA 1597-9601 G
10338930043ANTI-CARDIOLIPINA ELISA IgA EA 1621-9601 A
10338930044ANTI-GLIADINA GAF-3X ELISA IgA EV3011-9601 A
10338930045Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.
Next step
Medical device registration with ANVISA
HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.
Speak to a specialist